207 related articles for article (PubMed ID: 10102478)
1. Utilization of previously treated patients (PTPs), noninfected patients (NIPs), and previously untreated patients (PUPs) in the evaluation of new factor VIII and factor IX concentrates. Recommendation of the Scientific Subcommittee on Factor VIII and Factor IX of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
White GC; DiMichele D; Mertens K; Negrier C; Peake IR; Prowse C; Schwaab R; Yoshioka A; Ingerslev J
Thromb Haemost; 1999 Mar; 81(3):462. PubMed ID: 10102478
[No Abstract] [Full Text] [Related]
2. Registry of DNA polymorphisms within or close to the human factor VIII and factor IX genes. For the Factor VIII/IX Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
Peake I
Thromb Haemost; 1992 Feb; 67(2):277-80. PubMed ID: 1352417
[No Abstract] [Full Text] [Related]
3. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis.
White GC; Rosendaal F; Aledort LM; Lusher JM; Rothschild C; Ingerslev J;
Thromb Haemost; 2001 Mar; 85(3):560. PubMed ID: 11307831
[No Abstract] [Full Text] [Related]
4. The design and analysis of half-life and recovery studies for factor VIII and factor IX. Factor VIII/Factor IX Scientific and Standardization Committee of the International Society for Thrombosis and Haemostasis.
Morfini M; Lee M; Messori A
Thromb Haemost; 1991 Sep; 66(3):384-6. PubMed ID: 1746011
[No Abstract] [Full Text] [Related]
5. Clinical studies with treated clotting factor concentrates.
Colombo M; Mannucci PM
Dev Biol Stand; 1987; 67():333-6. PubMed ID: 3038639
[TBL] [Abstract][Full Text] [Related]
6. Virus safety of pasteurized factor VIII and factor IX concentrates: study in virgin patients.
Heimburger N; Karges HE; Weidmann E
Dev Biol Stand; 1987; 67():303-10. PubMed ID: 3038638
[TBL] [Abstract][Full Text] [Related]
7. Revision of the protocol recommended for studies of safety from hepatitis of clotting factor concentrates. International Society for Thrombosis and Hemostasis.
Mannucci PM; Colombo M
Thromb Haemost; 1989 Jun; 61(3):532-4. PubMed ID: 2508261
[No Abstract] [Full Text] [Related]
8. A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis.
Giles AR; Verbruggen B; Rivard GE; Teitel J; Walker I
Thromb Haemost; 1998 Apr; 79(4):872-5. PubMed ID: 9569207
[TBL] [Abstract][Full Text] [Related]
9. Report of the subcommittee on human factor VIII and factor IX preparations.
Brinkhous KM
Thromb Diath Haemorrh Suppl; 1968; 35():233. PubMed ID: 5761064
[No Abstract] [Full Text] [Related]
10. Recommendations of the subcommittee on human factor VIII (AHF) and factor IX (PTC) preparations.
Wagner RH
Thromb Diath Haemorrh Suppl; 1968; 35():235-7. PubMed ID: 5761065
[No Abstract] [Full Text] [Related]
11. Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTH.
Kasper CK; Aronson DL; Davignon G; Foster P; Hillman-Wiseman C; Lusher JM; Manco-Johnson M; Meade JB; Montgomery RR; Rickles FR
Thromb Haemost; 1995 Sep; 74(3):987-9. PubMed ID: 8571334
[TBL] [Abstract][Full Text] [Related]
12. [Viral hepatitis in hemophiliac patients treated with commercial concentrates of factors VIII and IX].
Miranda ML; Lissen E; Vinuesa M; Jiménez JM; García de Pesquera F; Leal M
Med Clin (Barc); 1985 Apr; 84(13):516-9. PubMed ID: 3923278
[No Abstract] [Full Text] [Related]
13. In vivo recovery of factor VIII following transfusion: a survey of recent data and publications to assess the influence of standards used for potency assignment. On behalf of the Subcommittee on Factor VIII and IX of the Scientific and Standardization Committee of the ISTH.
Prowse CV
Thromb Haemost; 1995 Oct; 74(4):1191-6. PubMed ID: 8560434
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma-derived FVIII or FIX concentrate: results from the French haemophilia cohort.
Gaboulaud V; Parquet A; Tahiri C; Claeyssens S; Potard V; Faradji A; Peynet J; Costagliola D;
Br J Haematol; 2002 Feb; 116(2):383-9. PubMed ID: 11841442
[TBL] [Abstract][Full Text] [Related]
15. Inhibitor treatment in haemophilias A and B: inhibitor diagnosis.
DiMichele DM
Haemophilia; 2006 Dec; 12 Suppl 6():37-41; discussion 41-2. PubMed ID: 17123392
[TBL] [Abstract][Full Text] [Related]
16. Concentrate safety and efficacy.
Kasper CK
Haemophilia; 2002 May; 8(3):161-5. PubMed ID: 12010404
[TBL] [Abstract][Full Text] [Related]
17. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
Hedner U
Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
[No Abstract] [Full Text] [Related]
18. [New approaches to haemophilia treatment--recombinant and transgenic concentrates, gene therapy and engineered coagulation factors].
Habart D
Cas Lek Cesk; 2006; 145(2):104-11. PubMed ID: 16521398
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and immune tolerance coagulation Factors VIII and IX.
Rup B
Dev Biol (Basel); 2003; 112():55-9. PubMed ID: 12762504
[TBL] [Abstract][Full Text] [Related]
20. Nomenclature of quantities and units in thrombosis and haemostasis (recommendation 1993). A Collaborative project of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (ISTH/SSC) and the Commission/Committee on Quantities and Units (in Clinical Chemistry) of the International Union of Pure and Applied Chemistry-International Federation of Clinical Chemistry (IUPAC-IFCC/CQU(CC)).
Blombäck M; Abildgaard U; van den Besselaar AM; Clementson KJ; Dahlbäck B; Exner T; Francis CW; Gaffney P; Gralnick H; Hoyer LW
Thromb Haemost; 1994 Mar; 71(3):375-94. PubMed ID: 8029803
[No Abstract] [Full Text] [Related]
[Next] [New Search]
